Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice

Journal of Bone and Mineral Metabolism

Volumn 26, Issue 6, 2008, Pages 642-647

  Nakamura, Hiroaki ^a   Hiraga, Toru ^a   Ninomiya, Tadashi ^a   Hosoya, Akihiro ^a   Fujisaki, Noboru ^a   Yoneda, Toshiyuki ^b   Ozawa, Hidehiro ^a  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Bone destruction; Bone marrow stromal cell; Bone metastasis; Breast cancer; Osteoclast

Indexed keywords

ALKALINE PHOSPHATASE; HERMES ANTIGEN; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOPONTIN; PARATHYROID HORMONE RELATED PROTEIN; CYTOKINE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; BONE METASTASIS; CANCER CELL; CELL MEMBRANE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INOCULATION; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STROMA CELL; ANIMAL; BONE TUMOR; BREAST TUMOR; CELL COMMUNICATION; CYTOLOGY; DISEASE MODEL; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD44; BONE NEOPLASMS; BREAST NEOPLASMS; CELL COMMUNICATION; CELL LINE, TUMOR; CYTOKINES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FEMALE; HUMANS; HYALURONIC ACID; MICE; MICE, NUDE; NEOPLASM METASTASIS; OSTEOCLASTS; OSTEOPROTEGERIN; PARATHYROID HORMONE-RELATED PROTEIN; RANK LIGAND;

EID: 58149214627     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-008-0857-1     Document Type: Article

References (30)

1. G.R. Mundy 2002 Metastasis to bone: causes, consequences and therapeutic opportunities Nat Rev Cancer 2 584 593
2. T. Yoneda T. Hiraga 2005 Crosstalk between cancer cells and bone microenvironment in bone metastasis Biochem Biophys Res Commun 328 679 687
3. A. Boyde E. Maconnachie S.A. Reid G. Delling G.R. Mundy 1986 Scanning electron microscopy in bone pathology: review of methods, potential and applications Scanning Electron Microsc 4 1537 1554
4. T. Hiraga S. Tanaka M. Ikegame M. Koizumi H. Iguchi T. Nakajima H. Ozawa 1998 Morphology of bone metastasis Eur J Cancer 34 230 239
5. T. Hiraga A. Myoui M.E. Choi H. Yoshikawa T. Yoneda 2006 Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor β enhances bone metastases in breast cancer Cancer Res 66 2067 2073
6. M. Ito N. Amizuka S. Tanaka Y. Funatsu-Ozawa S. Kenmotsu K. Oda T. Nakajima H. Ozawa 2003 Ultrastructural and cytobiological studies on possible interactions between PTHrP-secreting tumor cells, stromal cells, and bone cells J Bone Miner Metab 21 353 362
7. T. Shimamura N. Amizuka M. Li P.H. Freitas J.H. White J.E. Henderson S. Shingaki T. Nakajima H. Ozawa 2005 Histological observations on the microenvironment of osteolytic bone metastasis by breast carcinoma cell line Biomed Res 26 159 172
8. T. Suda N. Takahashi N. Udagawa E. Jimi M.T. Gillespie T.J. Martin 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr Rev 20 345 357
9. L.C. Hofbauer A. Neubauer A.E. Heufelder 2001 Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases Cancer (Phila) 92 460 470
10. G.D. Roodman 2006 Regulation of osteoclast differentiation Ann N Y Acad Sci 1068 100 109
11. M. Asagiri H. Takayanagi 2007 The molecular understanding of osteoclast differentiation Bone (NY) 40 251 264
12. J. Southby M.W. Kissin J.A. Danks J.A. Hayman J.M. Moseley M.A. Henderson R.C. Bennett T.J. Martin 1990 Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer Cancer Res 50 7710 7716
13. T.A. Guise J.J. Yin S.D. Taylor Y. Kumagai M. Dallas B.F. Boyce T. Yoneda G.R. Mundy 1996 Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis J Clin Invest 98 1544 1549
14. R.J. Thomas T.A. Guise J.J. Yin J. Elliott N.J. Horwood T.J. Martin M.T. Gillespie 1999 Breast cancer cells interact with osteoblasts to support osteoclast formation Endocrinology 140 4451 4458
15. S. Kitazawa R. Kitazawa 2002 RANK ligand is a prerequisite for cancer-associated osteolytic lesions J Pathol 198 228 236
16. K.P. McHugh Z. Shen T.N. Crotti M.R. Flannery R. Fajardo B.E. Bierbaum S.R. Goldring 2007 Role of cell-matrix interactions in osteoclast differentiation Adv Exp Med Biol 602 107 111
17. 3 integrins in osteoclast function J Bone Miner Metab 25 337 344
18. H. Nakamura S. Kenmotsu H. Sakai H. Ozawa 1995 Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae Cell Tissue Res 280 225 233
19. J.E. Draffin S. McFarlane A. Hill P.G. Johnston D.J. Waugh 2004 CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells Cancer Res 64 5702 5711
20. J. Bajorath 2000 Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions Proteins 39 103 111
21. E.A. Turley P.W. Noble L.Y. Bourguignon 2002 Signaling properties of hyaluronan receptors J Biol Chem 277 4589 4592
22. J.R. Kania T. Kehat-Stadler S.R. Kupfer 1997 CD44 antibodies inhibit osteoclast formation J Bone Miner Res 12 1155 1164
23. T.J. de Vries T. Schoenmaker W. Beertsen R. van der Neut V. Everts 2005 Effect of CD44 deficiency on in vitro and in vivo osteoclast formation (2005) J Cell Biochem 94 954 966
24. W. Ariyoshi T. Takahashi T. Kanno H. Ichimiya H. Takano T. Koseki T. Nishihara 2005 Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid J Biol Chem 280 18967 18972
25. S.R. Rittking H.N. Matsumoto M.D. McKee X.R. An K.E. Novick A.J. Kowalski M. Noda D.T. Denhardt 1998 Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro J Bone Miner Res 13 1101 1111
26. M.A. Chellaiah N. Kizer R. Biswas U. Alvarez J. Strauss-Schoenberger L. Rifas S.R. Rittling D.T. Denhardt K.A. Hruska 2003 Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression Mol Biol Cell 14 173 189
27. J.J. Cao P.A. Singleton S. Majumdar B. Boudignon A. Burghardt P. Kurimoto T.J. Wronski L.Y. Bourguignon B.P. Halloran 2005 Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44 J Bone Miner Res 20 30 40
28. H. Nakamura R. Kato A. Hirata M. Inoue T. Yamamoto 2005 Localization of CD44 (hyaluronan receptor) and hyaluronan in rat mandibular condyle J Histochem Cytochem 53 113 120
29. Y. Ohyama H. Nemoto S. Rittling K. Tsuji T. Amagasa D.T. Denhardt A. Nifuji M. Noda 2004 Osteopontin-deficiency suppresses growth of B16 melanoma cell implanted in bone and osteoclastogenesis in co-cultures J Bone Miner Res 19 1706 1711
30. P. Spessotto F.M. Rossi M. Degan R. Di Francia R. Perris A. Colombatti V. Gattei 2002 Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9 J Cell Biol 158 1133 1144